Ambu A/S (OTCMKTS:AMBBY) Posts Quarterly Earnings Results

Ambu A/S (OTCMKTS:AMBBY) released its quarterly earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a net margin of 8.86% and a return on equity of 9.15%.

Ambu A/S Stock Down 6.3%

OTCMKTS AMBBY traded down $0.67 during trading hours on Wednesday, reaching $9.98. 600 shares of the company traded hands, compared to its average volume of 159. Ambu A/S has a 12 month low of $9.70 and a 12 month high of $16.78. The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $2.35 billion, a PE ratio of 32.19 and a beta of 1.06. The company has a 50 day moving average of $10.91 and a two-hundred day moving average of $12.78.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.